2-(2,3-dicarboxycyclopropyl)glycine has been researched along with 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid in 1 studies
| Studies (2-(2,3-dicarboxycyclopropyl)glycine) | Trials (2-(2,3-dicarboxycyclopropyl)glycine) | Recent Studies (post-2010) (2-(2,3-dicarboxycyclopropyl)glycine) | Studies (3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid) | Trials (3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid) | Recent Studies (post-2010) (3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid) |
|---|---|---|---|---|---|
| 166 | 0 | 27 | 755 | 2 | 65 |
| Protein | Taxonomy | 2-(2,3-dicarboxycyclopropyl)glycine (IC50) | 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.1139 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.1139 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.1139 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.1139 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.1139 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.1139 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.1139 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Georgopoulos, P; Papatheodoropoulos, C; Petrides, T; Pofantis, H | 1 |
1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
| Article | Year |
|---|---|
Differences in paired-pulse inhibition and facilitation in the dentate gyrus and CA3 field between dorsal and ventral rat hippocampus.
Topics: Animals; Benzylamines; Biophysics; CA3 Region, Hippocampal; Cyclopropanes; Dentate Gyrus; Dose-Response Relationship, Drug; Electric Stimulation; Evoked Potentials; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GABA Antagonists; Glycine; In Vitro Techniques; Male; Nerve Net; Organophosphorus Compounds; Phosphinic Acids; Piperazines; Rats; Rats, Wistar; Statistics, Nonparametric | 2015 |